Profile
Full Name
Silence Therapeutics plcTicker Symbol
SLNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United KingdomIPO
September 8, 2020Indexes
Not includedEmployees
116Key Details
Price
$2.73(-2.32%)
Market cap
$129.16M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$43.26M(+36.71% YoY)
Annual EPS
-$0.99(+32.65% YoY)
PE ratio
-
Next earnings date
May 16, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Silence Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 7, 25 HC Wainwright & Co.
BuyMar 5, 25 Morgan Stanley
OverweightMar 4, 25 Goldman Sachs
SellMar 4, 25 BMO Capital
OutperformFeb 11, 25 Goldman Sachs
SellFeb 3, 25 HC Wainwright & Co.
BuyJan 29, 25 HC Wainwright & Co.
BuyDec 10, 24 Chardan Capital
BuyDec 9, 24 HC Wainwright & Co.
BuyNov 20, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Silence Therapeutics?
- Does Silence Therapeutics pay dividends?
- What sector is Silence Therapeutics in?
- What industry is Silence Therapeutics in?
- What country is Silence Therapeutics based in?
- When did Silence Therapeutics go public?
- Is Silence Therapeutics in the S&P 500?
- Is Silence Therapeutics in the NASDAQ 100?
- Is Silence Therapeutics in the Dow Jones?
- When was Silence Therapeutics's last earnings report?
- When does Silence Therapeutics report earnings?
- Should I buy Silence Therapeutics stock now?
What is the ticker symbol for Silence Therapeutics?
The ticker symbol for Silence Therapeutics is NASDAQ:SLN
Does Silence Therapeutics pay dividends?
No, Silence Therapeutics does not pay dividends
What sector is Silence Therapeutics in?
Silence Therapeutics is in the Healthcare sector
What industry is Silence Therapeutics in?
Silence Therapeutics is in the Biotechnology industry
What country is Silence Therapeutics based in?
Silence Therapeutics is headquartered in United Kingdom
When did Silence Therapeutics go public?
Silence Therapeutics's initial public offering (IPO) was on September 8, 2020
Is Silence Therapeutics in the S&P 500?
No, Silence Therapeutics is not included in the S&P 500 index
Is Silence Therapeutics in the NASDAQ 100?
No, Silence Therapeutics is not included in the NASDAQ 100 index
Is Silence Therapeutics in the Dow Jones?
No, Silence Therapeutics is not included in the Dow Jones index
When was Silence Therapeutics's last earnings report?
Silence Therapeutics's most recent earnings report was on Feb 27, 2025
When does Silence Therapeutics report earnings?
The next expected earnings date for Silence Therapeutics is May 16, 2025
Should I buy Silence Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions